Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Peregrine Pharmaceuticals Company Profile (NASDAQ:PPHM)

Consensus Ratings for Peregrine Pharmaceuticals (NASDAQ:PPHM) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $2.50 (85.19% upside)

Analysts' Ratings History for Peregrine Pharmaceuticals (NASDAQ:PPHM)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/13/2015MLV & Co.Set Price TargetBuy$3.50ViewTweet This Rating  Share This Rating on StockTwits
2/23/2015ZacksDowngradeOutperform -> Neutral$1.50ViewTweet This Rating  Share This Rating on StockTwits
1/23/2015ZacksUpgradeNeutral -> Outperform$1.70ViewTweet This Rating  Share This Rating on StockTwits
7/15/2014Roth CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
3/11/2014MLV & Co.Boost Price TargetBuy$2.50 -> $3.50ViewTweet This Rating  Share This Rating on StockTwits
1/17/2014JPMorgan Chase & Co.Lower Price Target$12.00 -> $9.50ViewTweet This Rating  Share This Rating on StockTwits
6/28/2013Roth CapitalLower Price Target$7.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
6/3/2013Roth CapitalBoost Price TargetBuy$4.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/31/2013 forward)